Publications by authors named "Roberta Pica"

Claim this Profile
E
Emotional Disturbances and Crohn's Disease.
Mara Lastretti, Ettore D'Aleo, Roberta Pica, Daniela De Nitto, Mauro Giovanni Carta

Clin Pract Epidemiol Ment Health· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Upadacitinib's Effectiveness and Safety as a Second- or Third-Line Therapy in Patients with Ulcerative Colitis: Data from a Real-World Study.
Giammarco Mocci, Antonio Tursi, Franco Scaldaferri, Daniele Napolitano, Daniela Pugliese, Roberta Pica

J Clin Med· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Filgotinib effectiveness and safety as second or third-line therapy in patients with ulcerative colitis: data from a real-world study.
Antonio Tursi, Giammarco Mocci, Francesco Costa, Linda Ceccarelli, Edoardo Savarino, Roberta Pica

Intest Res· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-Term Effectiveness and Safety of Ustekinumab in Crohn's Disease: Results from a Large Real-Life Cohort Study.
Giammarco Mocci, Antonio Tursi, Franco Scaldaferri, Daniele Napolitano, Daniela Pugliese, Roberta Pica

J Clin Med· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Floating knee: A new prognostic classification.
Luigi Meccariello, Roberta Pica, Rocco Erasmo, Mario Ronga, Francesco Ippolito

Injury· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Ustekinumab safety and effectiveness in patients with ulcerative colitis: results from a large real-life study.
Antonio Tursi, Giammarco Mocci, Franco Scaldaferri, Daniele Napolitano, Rossella Maresca, Roberta Pica

Expert Opin Biol Ther· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Use of tofacitinib as first or second-line therapy is associated with better outcomes in patients with ulcerative colitis: data from a real-world study.
Antonio Tursi, Giammarco Mocci, Linda Cingolani, Edoardo Savarino, Roberta Pica

Expert Opin Pharmacother· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of Performances of Adalimumab Biosimilars SB5, ABP501, GP2017, and MSB11022 in Treating Patients with Inflammatory Bowel Diseases: A Real-Life, Multicenter, Observational Study.
Antonio Tursi, Giammarco Mocci, Leonardo Allegretta, Giovanni Aragona, Maria Antonia Bianco, Roberta Pica

Inflamm Bowel Dis· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world efficacy and safety of vedolizumab in managing ulcerative colitis versus Crohn's disease: results from an Italian multicenter study.
Giammarco Mocci, Antonio Tursi, Giovanni Maconi, Giovanni Cataletti, Beatrice Mantia, Roberta Pica

Expert Opin Biol Ther· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antibiotic-Loaded Coatings to Reduce Fracture-Related Infections: Retrospective Case Series of Patients with Increased Infectious Risk.
Daniele De Meo, Gianluca Cera, Roberta Pica, Fabiano Perfetti, Paolo Martini

Antibiotics (Basel)· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Replacement of Adalimumab Originator to Adalimumab Biosimilar for a Non-Medical Reason in Patients with Inflammatory Bowel Disease: A Real-life Comparison of Adalimumab Biosimilars Currently Available in Italy.
Antonio Tursi, Giammarco Mocci, Antonio Cuomo, Antonio Ferronato, Walter Elisei, Roberta Pica

J Gastrointestin Liver Dis· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of performances of infliximab biosimilars CT-P13 versus SB2 in the treatment of inflammatory bowel diseases: a real-life multicenter, observational study in Italy.
Antonio Tursi, Giammarco Mocci, Leonardo Allegretta, Giovanni Aragona, Maria Antonia Bianco, Roberta Pica

Expert Opin Biol Ther· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment of Unstable Elbow Injuries with a Hinged Elbow Fixator: Subjective and Objective Results.
Luigi Meccariello, Vincenzo Caiaffa, Konrad Mader, Ante Prkic, Denise Eygendaal, Giuseppe Pica, Roberta Pica

Strategies Trauma Limb Reconstr· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hepatitis B (HBV) reactivation in patients receiving biologic therapy for chronic inflammatory diseases in clinical practice.
Lorenzo Ridola, Angelo Zullo, Bruno Laganà, Roberto Lorenzetti, Alberto Migliore, Roberta Pica

Ann Ist Super Sanita· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SARS-CoV-2: lessons from both the history of medicine and from the biological behavior of other well-known viruses.
Sirio Fiorino, Fabio Tateo, Dario De Biase, Claudio G Gallo, Paolo E Orlandi, Roberta Pica

Future Microbiol· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term real-life efficacy and safety of infliximab and adalimumab in the treatment of inflammatory bowel diseases outpatients.
Antonio Tursi, Giammarco Mocci, Roberto Lorenzetti, Leonardo Allegretta, Giovanni Brandimarte, Roberta Pica

Eur J Gastroenterol Hepatol· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An Ulcerated Large Colic Lipoma Causing Rectorrhagia Treated With Endoscopic Loop-Assisted Resection.
Maddalena Zippi, Antonella Toma, Nada Paoluzi, Francesca Maccioni, Roberta Pica

Cureus· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Paradoxical relationship between proton pump inhibitors and COVID-19: A systematic review and meta-analysis.
Maddalena Zippi, Sirio Fiorino, Roberta Budriesi, Matteo Micucci, Ivan Corazza, Roberta Pica

World J Clin Cases· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multicenter Validation of the DETAIL Questionnaire for the Screening of Spondyloarthritis in Patients With Inflammatory Bowel Diseases.
Devis Benfaremo, Michele Maria Luchetti, Marco Di Carlo, Bruno Laganà, Andrea Picchianti-Diamanti, Roberta Pica

J Rheumatol· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vitamin D Signaling in Gastro-Rheumatology: From Immuno-Modulation to Potential Clinical Applications.
Cristiano Pagnini, Andrea Picchianti-Diamanti, Vincenzo Bruzzese, Roberto Lorenzetti, Michele Maria Luchetti, Roberta Pica

Int J Mol Sci· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Candida Albicans Lung Abscess in an Illicit Drugs User With Hepatitis C Virus Chronic Infection.
Maddalena Zippi, Antonella Toma, Francesca Maccioni, Roberta Pica

Cureus· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Splenic Hematoma as a Rare Complication of Colonoscopy; a Case Report.
Maddalena Zippi, Roberta Pica, Ingrid Febbraro, Francesco Rocco Pugliese, Francesca Liguori

Arch Acad Emerg Med· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anti-CXCL4 Antibody Reactivity Is Present in Systemic Sclerosis (SSc) and Correlates with the SSc Type I Interferon Signature.
Roberto Lande, Anna Mennella, Raffaella Palazzo, Immacolata Pietraforte, Katia Stefanantoni, Roberta Pica

Int J Mol Sci· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
IL-13 mRNA Tissue Content Identifies Two Subsets of Adult Ulcerative Colitis Patients With Different Clinical and Mucosa-Associated Microbiota Profiles.
Alessia Butera, Monica Di Paola, Francesco Vitali, Daniela De Nitto, Francesco Covotta, Roberta Pica

J Crohns Colitis· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CD3+CD4+LAP+Foxp3-Regulatory Cells of the Colonic Lamina Propria Limit Disease Extension in Ulcerative Colitis.
Alessia Butera, Massimo Sanchez, Annamaria Pronio, Antonello Amendola, Daniela De Nitto, Roberta Pica

Front Immunol· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis